Why the study?
Apolipoprotein B is implicated in cardiometabolic disorders beyond dyslipidemia, but its role in glycemic dysregulation remains unclear.
Are elevated Apolipoprotein B (ApoB) levels associated with glycemic dysregulation and increased odds of prediabetes/type 2 diabetes in high-cardiovascular-risk individuals in Kazakhstan?
Are elevated Apolipoprotein B (ApoB) levels associated with glycemic dysregulation and increased odds of prediabetes/type 2 diabetes in high-cardiovascular-risk individuals in Kazakhstan?
Answers are grounded in this paper and cite their sources.
Elevated ApoB and triglyceride levels, unlike Lp(a), are independently associated with adverse glycemic parameters and prediabetes/diabetes in high-cardiovascular-risk patients in Kazakhstan, supporting integrated lipid and glycemic risk stratification.
Background: Apolipoprotein B (ApoB), a key component of atherogenic lipoproteins, has been increasingly implicated in cardiometabolic disorders beyond dyslipidemia. However, its role in glycemic dysregulation remains unclear. This study aimed to investigate the association between ApoB levels and glycemic parameters, including fasting glucose, insulin resistance, and glycated hemoglobin (HbA1c), in individuals without diagnosed diabetes. Methods: This study was conducted at the National Research Cardiac Surgery Center (Kazakhstan) over the period between 2023 and 2024 as a cross-sectional analysis. Adults aged ≥ 20 years without diagnosed diabetes and with complete data on their ApoB and glycemic markers were included. Associations between ApoB and fasting plasma glucose (FPG), HbA1c, and HOMA-IR were assessed using multivariable linear and logistic regression models adjusted for demographic, lifestyle, and metabolic covariates. Results: Higher ApoB levels were significantly associated with increased fasting glucose (β = 2.07 mg/dL per 1-SD increase in ApoB, p < 0.001), higher HbA1c (β = 0.06%, p < 0.001), and elevated HOMA-IR (β = 0.54, p < 0.001). Participants in the highest ApoB quartile had 53% higher odds of prediabetes (adjusted OR = 1.53; 95% CI: 1.22–1.91; p < 0.001) compared to the lowest quartile. These associations remained significant after adjusting for BMI, lipid levels, and other confounders. Conclusions: Elevated ApoB is independently associated with adverse glycemic profiles in nondiabetic individuals, suggesting its potential role in early glucose metabolism disturbances.
No takes yet. Share an insight, caveat, or question.
Bekbossynova et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: